An unusual case of Lafora body disease
Related Experiment Video
Updated: Oct 24, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
1Magnetic Resonance Spectroscopy Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Abstract:
A case is described in which non-convulsive status epilepticus (NCSE) prompted further investigation leading to the diagnosis of Lafora body disease (LBD). The onset of NCSE was temporally related to the withdrawal of sodium valproate and introduction of carbamazepine, which may have been precipitating factors. NCSE has not previously been reported in LBD. Implications for its drug management are discussed.
Related Concept Videos
Lysosomal Hydrolases
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Toxoplasmosis
Brain Abscess l: Introduction
Graves' Disease I: Introduction
Hepatic Encephalopathy
